Uncovering Tumor‐Promoting Roles of Activin A in Pancreatic Ductal Adenocarcinoma
Source abstract
Abstract
Abstract Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers with high incidence rates of metastasis and cachexia. High circulating activin A, a homodimer of inhibin βA subunits that are encoded by INHBA gene, predicts poor survival among PDAC patients. However, it still raises the question of whether activin A suppression renders favorable PDAC outcomes. Here, the authors demonstrate that activin A is abundantly detected in tumor and stromal cells on PDAC tissue microarray and mouse PDAC sections. In orthotopic male mice, activin A suppression, which is acquired by tumor‐targeted Inhba siRNA using cholesterol‐modified polymeric nanoparticles, retards tumor growth/metastasis and cachexia and improves survival when compared to scramble siRNA‐treated group. Histologically, activin A suppression coincides with decreased expression of proliferation marker Ki67 but increased accumulation of α‐SMAhigh fibroblasts and cytotoxic T cells in the tumors. In vitro data demonstrate that activin A promotes KPC cell proliferation and induces the downregulation of α‐SMA and upregulation of IL‐6 in pancreatic stellate cells (PSC) in the SMAD3‐dependent mechanism. Moreover, conditioned media from activin A‐stimulated PSC promoted KPC cell growth. Collectively, our data provide a mechanistic basis for tumor‐promoting roles of activin A and support therapeutic potentials of tumor activin A suppression for PDAC.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Pancreatic and Hepatic Oncology Research · TGF-β signaling in diseases · Caveolin-1 and cellular processes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Olson Center for Women's Health Department of Obstetrics and Gynecology College of Medicine University of Nebraska Medical Center Omaha NE USA
Center for Drug Delivery and Nanomedicine Department of Pharmaceutical Sciences College of Pharmacy University of Nebraska Medical Center Omaha NE USA
Eppley Institute for Research in Cancer and Allied Diseases University of Nebraska Medical Center Omaha NE 68198 USA
Fred & Buffett Cancer Center University of Nebraska Medical Center Omaha NE USA
Funding
University of Nebraska Medical Center
References (45)
Show source-provided references
1. 10.1016/j.ccell.2017.07.00710.1016/j.ccell.2017.07.007 ↗
2. 10.3322/caac.2159010.3322/caac.21590 ↗
3. 10.4081/oncol.2019.41010.4081/oncol.2019.410 ↗
4. 10.3389/fonc.2021.68837710.3389/fonc.2021.688377 ↗
5. 10.1042/BSR2021252310.1042/BSR20212523 ↗
6. 10.1002/path.414210.1002/path.4142 ↗
7. 10.1152/physrev.00002.201810.1152/physrev.00002.2018 ↗
8. 10.1038/s42003-022-04388-410.1038/s42003-022-04388-4 ↗
9. 10.3390/cancers701007010.3390/cancers7010070 ↗
10. 10.1074/jbc.M40948620010.1074/jbc.M409486200 ↗
11. 10.1016/j.mce.2013.03.02110.1016/j.mce.2013.03.021 ↗
12. 10.1210/me.2006-018210.1210/me.2006-0182 ↗
13. 10.1095/biolreprod.112.10412510.1095/biolreprod.112.104125 ↗
14. 10.1038/s41598-022-05660-710.1038/s41598-022-05660-7 ↗
15. 10.1038/s41598-021-87213-y10.1038/s41598-021-87213-y ↗
16. 10.1002/jcsm.1246110.1002/jcsm.12461 ↗
17. 10.1038/labinvest.2014.5310.1038/labinvest.2014.53 ↗
18. 10.3389/fcell.2021.65515210.3389/fcell.2021.655152 ↗
19. 10.3390/cancers1319493210.3390/cancers13194932 ↗
20. 10.1038/s41467-021-26059-410.1038/s41467-021-26059-4 ↗
21. 10.1186/s13073-020-00776-910.1186/s13073-020-00776-9 ↗
22. 10.1016/j.ebiom.2021.10331510.1016/j.ebiom.2021.103315 ↗
23. 10.1016/j.ccr.2014.04.00510.1016/j.ccr.2014.04.005 ↗
24. 10.1053/j.gastro.2020.09.01010.1053/j.gastro.2020.09.010 ↗
25. 10.1053/j.gastro.2018.05.05110.1053/j.gastro.2018.05.051 ↗
26. 10.1084/jem.2019045010.1084/jem.20190450 ↗
27. Zhao Z. · Aging · 2020 · 12
28. 10.1038/s41419-021-03920-410.1038/s41419-021-03920-4 ↗
29. 10.1159/00047777310.1159/000477773 ↗
30. 10.3389/fonc.2021.64639910.3389/fonc.2021.646399 ↗
31. 10.3390/cells810111810.3390/cells8101118 ↗
32. 10.3390/cells904104010.3390/cells9041040 ↗
33. 10.1158/1078-0432.CCR-21-159110.1158/1078-0432.CCR-21-1591 ↗
34. 10.1021/acsnano.9b0397810.1021/acsnano.9b03978 ↗
35. 10.1016/j.canlet.2018.12.00510.1016/j.canlet.2018.12.005 ↗
36. 10.1158/0008-5472.CAN-19-376310.1158/0008-5472.CAN-19-3763 ↗
37. 10.1016/j.canlet.2014.10.03710.1016/j.canlet.2014.10.037 ↗
38. 10.1053/j.gastro.2013.01.07010.1053/j.gastro.2013.01.070 ↗
39. Wang S. · Am. J. Cancer Res. · 2020 · 10 · 1937
40. 10.3390/cancers1319502810.3390/cancers13195028 ↗
41. 10.1186/s12935-017-0437-310.1186/s12935-017-0437-3 ↗
42. 10.1084/jem.2016202410.1084/jem.20162024 ↗
43. 10.1053/j.gastro.2015.09.01310.1053/j.gastro.2015.09.013 ↗
44. 10.1101/gad.147870610.1101/gad.1478706 ↗
45. 10.1016/j.molonc.2013.02.00210.1016/j.molonc.2013.02.002 ↗